197 related articles for article (PubMed ID: 10490823)
21. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
Altomare DA; Guo K; Cheng JQ; Sonoda G; Walsh K; Testa JR
Oncogene; 1995 Sep; 11(6):1055-60. PubMed ID: 7566964
[TBL] [Abstract][Full Text] [Related]
22. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis.
Cheng JQ; Altomare DA; Klein MA; Lee WC; Kruh GD; Lissy NA; Testa JR
Oncogene; 1997 Jun; 14(23):2793-801. PubMed ID: 9190895
[TBL] [Abstract][Full Text] [Related]
23. Frequent activation of AKT2 kinase in human pancreatic carcinomas.
Altomare DA; Tanno S; De Rienzo A; Klein-Szanto AJ; Tanno S; Skele KL; Hoffman JP; Testa JR
J Cell Biochem; 2002; 87(4):470-6. PubMed ID: 14735903
[TBL] [Abstract][Full Text] [Related]
24. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines.
Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY
Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.
Minakuchi M; Kakazu N; Gorrin-Rivas MJ; Abe T; Copeland TD; Ueda K; Adachi Y
Eur J Biochem; 2001 Mar; 268(5):1340-51. PubMed ID: 11231286
[TBL] [Abstract][Full Text] [Related]
26. A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) Domain.
Akhtar N; Jabeen I
PLoS One; 2016; 11(12):e0168806. PubMed ID: 28036396
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21.
Clark CC; Cohen I; Eichstetter I; Cannizzaro LA; McPherson JD; Wasmuth JJ; Iozzo RV
Genomics; 1993 Nov; 18(2):249-60. PubMed ID: 8288227
[TBL] [Abstract][Full Text] [Related]
28. AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation.
Datta K; Franke TF; Chan TO; Makris A; Yang SI; Kaplan DR; Morrison DK; Golemis EA; Tsichlis PN
Mol Cell Biol; 1995 Apr; 15(4):2304-10. PubMed ID: 7891724
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3.
Masure S; Haefner B; Wesselink JJ; Hoefnagel E; Mortier E; Verhasselt P; Tuytelaars A; Gordon R; Richardson A
Eur J Biochem; 1999 Oct; 265(1):353-60. PubMed ID: 10491192
[TBL] [Abstract][Full Text] [Related]
30. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.
Kannan K; Coarfa C; Chao PW; Luo L; Wang Y; Brinegar AE; Hawkins SM; Milosavljevic A; Matzuk MM; Yen L
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1272-7. PubMed ID: 25733895
[TBL] [Abstract][Full Text] [Related]
31. Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene.
Altomare DA; Kozak CA; Sonoda G; Testa JR
Cytogenet Cell Genet; 1996; 74(4):248-51. PubMed ID: 8976376
[TBL] [Abstract][Full Text] [Related]
32. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site.
Nakatani K; Sakaue H; Thompson DA; Weigel RJ; Roth RA
Biochem Biophys Res Commun; 1999 Apr; 257(3):906-10. PubMed ID: 10208883
[TBL] [Abstract][Full Text] [Related]
33. Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides.
Chial HJ; Wu R; Ustach CV; McPhail LC; Mobley WC; Chen YQ
Traffic; 2008 Feb; 9(2):215-29. PubMed ID: 18034774
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel protein, DMAP, which interacts with the myotonic dystrophy protein kinase and shows strong homology to D1 snRNP.
Fu YH
Genetica; 1996 Jan; 97(1):117-25. PubMed ID: 8851885
[TBL] [Abstract][Full Text] [Related]
35. CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain.
Connelly MA; Marcu KB
Cell Mol Biol Res; 1995; 41(6):537-49. PubMed ID: 8777433
[TBL] [Abstract][Full Text] [Related]
36. APPL suppresses androgen receptor transactivation via potentiating Akt activity.
Yang L; Lin HK; Altuwaijri S; Xie S; Wang L; Chang C
J Biol Chem; 2003 May; 278(19):16820-7. PubMed ID: 12621049
[TBL] [Abstract][Full Text] [Related]
37. Interactions between GIPC-APPL and GIPC-TRP1 regulate melanosomal protein trafficking and melanogenesis in human melanocytes.
Kedlaya R; Kandala G; Liu TF; Maddodi N; Devi S; Setaluri V
Arch Biochem Biophys; 2011 Apr; 508(2):227-33. PubMed ID: 21291857
[TBL] [Abstract][Full Text] [Related]
38. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel gene encoding a p53-associated protein.
Zhou R; Wen H; Ao SZ
Gene; 1999 Jul; 235(1-2):93-101. PubMed ID: 10415337
[TBL] [Abstract][Full Text] [Related]
40. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner.
Kovacina KS; Park GY; Bae SS; Guzzetta AW; Schaefer E; Birnbaum MJ; Roth RA
J Biol Chem; 2003 Mar; 278(12):10189-94. PubMed ID: 12524439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
